While 2025 began on a positive note for the pharmaceutical industry, things have taken a sharp turn amid escalating fears of a global trade war. While Trump had initially exempted pharmaceuticals from ...
You’d think companies would want their products’ names to be memorable, catchy and descriptive: Windex, Duracell, KitchenAid. So why has Big Pharma been doing the exact opposite for the past few years ...
The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on ...
Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...
Tariffs on pharmaceutical companies isn't just good economic policy - it benefits national security and public health More than 90% of U.S. prescriptions are for generic drugs, yet more than 80% of ...
India's first private drug quality audit finds generics match branded medicines for safety and efficacy—at a fraction of the price—reviving questions over doctors' reluctance to prescribe them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results